National registry for pediatric inflammatory brain diseases in Switzerland
Official title: Swiss Pediatric Inflammatory Bain Disease Cohort Study
Run by University of Bern · NCT05017142 · Data updated 2026-11-12
This study is collecting information on children with inflammatory brain diseases in Switzerland to see how to better diagnose and treat these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 36 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Bern Academic / other |
| Locations | 13 sites (Aarau, Canton of Aargau and 12 other locations) |
| Status | Recruiting |
| Started | April 14, 2020 |
| Main results expected | January 1, 2071 |
| Study ends | January 1, 2071 |
| Registry record updated | December 16, 2024 |
| Trial ID | NCT05017142 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pediatric patients diagnosed with specified inflammatory brain diseases before the age of 18 and living or being treated in Switzerland.
✕Probably not a fit
Patients diagnosed with inflammatory brain diseases after the age of 18 or those not residing in Switzerland may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Swiss Pediatric Inflammatory Brain Disease Registry collects comprehensive data on pediatric patients diagnosed with inflammatory brain diseases, including conditions like optic neuritis and multiple sclerosis. Implemented in 2020, it aims to improve diagnosis, treatment, and management of these conditions through systematic data collection across multiple centers in Switzerland. The registry facilitates research and enhances collaboration among clinicians and researchers, ultimately striving to optimize healthcare and quality of life for affected children.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis and treatment strategies for children with inflammatory brain diseases.
How similar studies have gone: Other national registries for similar conditions have shown success in improving patient outcomes and understanding disease epidemiology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients living and/or treated in Switzerland with an IBrainD specified in the following list diagnosed from 2005 onward and with a disease onset before the age of 18. * Written informed consent by patients (and/or legal representative(s), if applicable) * Optic Neuritis * Transverse Myelitis * Acute disseminated encephalomyelitis * Multiple Sclerosis * Neuromyelitis Optica Spectrum Disorders * Myelin oligodendrocyte glycoprotein antibody-associated disease * Anti-NMDA-R Encephalitis * Anti-GAD65 Associated Autoimmune Encephalitis * Anti-AMPAR-1/2 Associated Autoimmune Encephalitis * Anti-Lgi-1 Associated Autoimmune Encephalitis * Anti-CASPR-2 Associated Autoimmune Encephalitis * Anti-GABAR-1/2 Associated Autoimmune Encephalitis * Onconeuronal Antibody (Hu, Ri, Yo, Amphiphysin, CRMP-5, Ma-1, Ma-2, SOX-1) Associated Autoimmune Encephalitis * Hashimoto Encephalopathy * CNS Vasculitis * CNS Sarcoidosis * CNS Lupus * Rasmussen Encephalitis Exclusion Criteria: * Neurological symptoms due to infectious diseases of the CNS * Genetic/metabolic causes of central demyelinating diseases * Neurological symptoms due to Guillain-Barré-Syndrome
Where it's running
-
Kantonsspital Aarau
Aarau, Canton of Aargau, Switzerland Recruiting -
Children's Hospital of Eastern Switzerland
Sankt Gallen, Canton of St. Gallen, Switzerland Recruiting -
University Children's Hospital Lausanne (CHUV)
Lausanne, Canton of Vaud, Switzerland Recruiting -
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland Recruiting -
Pediatric Institute of Southern Switzerland, Ospedale San Giovanni
Bellinzona, Canton Ticino, Switzerland Recruiting -
Kantonsspital Graubünden
Chur, Kanton Graubünden, Switzerland Recruiting
Show 7 more locations
-
University Children's Hospital Basel, UKBB
Basel, Switzerland Recruiting -
University Children's Hospital, Inselspital Bern
Bern, Switzerland Recruiting -
Institute of Social and Preventive Medicine, University of Bern
Bern, Switzerland Recruiting -
University Hospitals of Geneva (HUG)
Geneva, Switzerland Recruiting -
Kinderspital Zentralschweiz
Lucerne, Switzerland Recruiting -
University Children's Hospital Zurich
Zurich, Switzerland Recruiting -
Hôpital Fribourgeois - Freiburger Spital
Fribourg, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Sandra Bigi, PD MD — ISPM, University of Bern, Bern; Kinderspital Zentralschweiz, Luzern
- Study coordinator: Lorena F Hulliger, MSc
- Email: lorena.hulliger@unibe.ch
- Phone: +41316845678
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Identifying biomarkers for autoimmune diseases affecting the nervous system
This study is trying to find specific markers in the blood of people with autoimmune diseases affecting the nervous system, like Multiple Sclerosis, to help with early diagnosis and better treatment options.
-
Using Calculus Bovis Sativus to treat inflammatory demyelinating diseases
This study is testing if a traditional Chinese medicine called Calculus Bovis Sativus can help people with conditions like multiple sclerosis feel better and reduce inflammation.
-
Using CT103A cells to treat autoimmune diseases of the nervous system
This study is testing if a new treatment using CT103A cells can help people with certain autoimmune diseases affecting the nervous system feel better.
-
OPM-MEG Brain Imaging in Young People with Immune- and Non-immune Related Neurological Disease
Researchers will test a fancy, child-friendly brain scan (OPM-MEG) to see how brain networks look in kids with autoimmune or other brain diseases and how that relates to their symptoms.
-
Pregnant Women with Neuroimmune Diseases: A long-term follow-up study
This study follows women with neuroimmune diseases and healthy controls through pregnancy and up to ten years to see how pregnancy affects disease activity and outcomes for both mother and baby.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.